Hims & Hers Health (HIMS) Treasury Shares (2019 - 2026)
Hims & Hers Health (HIMS) reported Treasury Shares of $19.6 million for Q1 2026, up 15.98% on a YoY basis from $16.9 million in Q1 2025, and up 49.74% sequentially from $13.1 million in Q4 2025.
Hims & Hers Health (HIMS) Treasury Shares (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Treasury Shares data on file, last reported at $19.6 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 15.98% year-over-year to $19.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.6 million (up 15.98% YoY), and the FY2025 full-year result was $13.1 million, down 17.02% from the prior year.
- Treasury Shares grew to $19.6 million in Q1 2026, from $13.1 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $20.4 million in Q1 2024 to a low of $7.3 million in Q1 2022.
- A 5-year average of $14.8 million and a median of $15.5 million in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares jumped 132.37% in 2023 and fell 17.27% in 2025, its largest moves.
- Tracing HIMS's Treasury Shares over 5 years: stood at $11.6 million in 2022, then rose by 24.84% to $14.5 million in 2023, then rose by 8.8% to $15.8 million in 2024, then slipped by 17.02% to $13.1 million in 2025, then soared by 49.74% to $19.6 million in 2026.
- Business Quant data shows HIMS's Treasury Shares at $19.6 million in Q1 2026, $13.1 million in Q4 2025, and $14.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn | 19.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.58 Mn |
| Mar 31, 2026 | 19.58 Mn |
| Dec 31, 2025 | 13.08 Mn |
| Dec 31, 2025 | 13.08 Mn |
| Sep 30, 2025 | 14.45 Mn |
| Sep 30, 2025 | 14.45 Mn |
| Jun 30, 2025 | 15.93 Mn |
| Jun 30, 2025 | 15.93 Mn |
| Mar 31, 2025 | 16.88 Mn |
| Mar 31, 2025 | 16.88 Mn |
| Dec 31, 2024 | 15.76 Mn |
| Dec 31, 2024 | 15.76 Mn |
| Sep 30, 2024 | 16.92 Mn |
| Sep 30, 2024 | 16.92 Mn |
| Jun 30, 2024 | 18.56 Mn |
| Jun 30, 2024 | 18.56 Mn |
| Mar 31, 2024 | 20.41 Mn |
| Mar 31, 2024 | 20.41 Mn |
| Dec 31, 2023 | 14.48 Mn |
| Dec 31, 2023 | 14.48 Mn |